Magnesium chloride and ruthenium red attenuate the antiallodynic effect of intrathecal gabapentin in a rat model of postoperative pain

Anesthesiology

Volumn 98, Issue 6, 2003, Pages 1472-1479

  Cheng, Jen Kun ^a,b   Lai, Yu Jun ^a   Chen, Chien Chuan ^a   Cheng, Ching Rong ^a   Chiou, Lih Chu ^b  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; GABAPENTIN; ISOFLURANE; MAGNESIUM CHLORIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN SUBUNIT; RUTHENIUM RED; SPERMINE;

ALLODYNIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; MALE; NONHUMAN; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RAT;

ACETIC ACIDS; AMINES; ANALGESICS; ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ANIMAL; CALCIUM CHANNELS; CYCLOHEXANECARBOXYLIC ACIDS; GAMMA-AMINOBUTYRIC ACID; HYPERALGESIA; INJECTIONS, SPINAL; MAGNESIUM CHLORIDE; MALE; MORPHINE; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; RUTHENIUM RED; SPERMINE;

EID: 0038443910     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200306000-00026     Document Type: Article

References (59)

1. Hwang JH, Yaksh TL: Effect of subarachnoid gabapentin on tactile-evoked allodynia in a surgically induced neuropathic pain model in the rat. Reg Anesth 1997; 22:249-56
2. Cheng JK, Pan HL, Eisenach JC: Antiallodynic effect of intrathecal gabapentin and its interaction with clonidine in a rat model of postoperative pain. ANESTHESIOLOGY 2000; 92:1126-31
3. Backonja M, Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M, LaMoreaux L, Garofalo E: Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial. JAMA 1998; 280:1831-6
4. Nicholson B: Gabapentin use in neuropathic pain syndromes. Acta Neurol Scand 2000; 101:359-71
5. Pollack MH, Matthews J, Scott EL: Gabapentin as a potential treatment for anxiety disorders. Am J Psychiatry 1998; 155:992-3
6. Wang PW, Santosa C, Schumacher M, Winsberg ME, Strong C, Ketter TA: Gabapentin augmentation therapy in bipolar depression. Bipolar Disord 2002; 4:296-301
7. Loprinzi L, Barton DL, Sloan JA, Zahasky KM, Smith de AR, Pruthi S, Novotny PJ, Perez EA, Christensen BJ: Pilot evaluation of gabapentin for treating hot flashes. Mayo Clin Proc 2002; 77:1159-63
8. Taylor CP, Gee NS, Su TZ, Kocsis JD, Welty DF, Brown JP, Dooley DJ, Boden P, Singh L: A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res 1998; 29:233-49
9. 3H]gabapentin binding to a novel site in rat brain: Homogenate binding studies. Eur J Pharmacol 1993; 244:293-301
10. Ng GY, Bertrand S, Sullivan R, Ethier N, Wang J, Yergey J, Belley M, Trimble L, Bateman K, Alder L, Smith A, McKernan R, Metters K, O'Neill GP, Lacaille JC, Hebert TE: γ-Aminobutyric acid type B receptors with specific heterodimer composition and postsynaptic actions in hippocampal neurons are targets of anticonvulsant gabapentin action. Mol Pharmacol 2001; 59:144-52
11. Bertrand S, Ng GY, Purisai MG, Wolfe SE, Severidt MW, Nouel D, Robitaille R, Low MJ, O'Neill GP, Metters K, Lacaille JC, Chronwall BM, Morris SJ: The anticonvulsant, antihyperalgesic agent gabapentin is an agonist at brain γ-aminobutyric acid type B receptors negatively coupled to voltage-dependent calcium channels. J Pharmacol Exp Ther 2001; 298:15-24
12. Kuzniecky R, Ho S, Pan J, Martin R, Gilliam F, Faught E, Hetherington H: Modulation of cerebral GABA by topiramate, lamotrigine, and gabapentin in healthy adults. Neurology 2002; 58:368-72
13. Petroff OA, Rothman DL, Behar KL, Lamoureux D, Mattson RH: The effect ofgabapentin on brain γ-aminobutyric acid in patients with epilepsy. Ann Neurol 1996; 39:95-9
14. Taylor CP, Vartanian MG, Andruszkiewicz R, Silverman RB: 3-alkyl GABA and 3-alkylglutamic acid analogues: Two new classes of anticonvulsant agents. Epilepsy Res 1992; 11:103-10
15. Honmou O, Oyelese AA, Kocsis JD: The anticonvulsant gabapentin enhances promoted release of GABA in hippocampus: A field potential analysis. Brain Res 1995; 692:273-7
16. 2δ calcium channel subunit. Br J Pharmacol 1997; 120:833-40
17. Gu Y, Huang LY: Gabapentin potentiates N-methyl-D-aspartate receptor mediated currents in rat GABAergic dorsal horn neurons. Neurosci Lett 2002; 324:177-80
18. Shimoyama M, Shimoyama N, Hori Y: Gabapentin affects glutamatergic excitatory, neurotransmission in the rat dorsal horn. Pain 2000; 85:405-14
19. Chizh BA, Scheede M, Schlutz H: Antinociception and (R,S)-alpha-amino3-hydroxy-5-methyl-4-isoxazole propionic acid antagonism by gabapentin in the rat spinal cord in vivo. Naunyn Schmiedebergs Arch Pharmacol 2000; 362:197-200
20. ATP channels. Naunyn Schmiedebergs Arch Pharmacol 2001; 363:537-42
21. 2δ subunit of a calcium channel. J Biol Chem 1996; 271:5768-76
22. 3H]gabapentin binding by ruthenium red. Neuropharmacology 2000; 39:1267-73
23. 2δ subunit of a calcium channel and their evaluation as anticonvulsant agents. J Med Chem 1998; 41:1838-45
24. 2δ subunit of voltage dependent calcium channels in models of neuropathic pain. Br J Pharmacol 2000; 131:282-6
25. 2δ for gabapentin binding. Biochem J 1999; 342:313-20
26. Brennan TJ, Vandermeulen EP, Gebhart GF: Characterization of a rat model of incisional pain. Pain 1996; 64:493-501
27. Su TZ, Lunney E, Campbell G, Oxender DL: Transport of gabapentin, a α-amino acid drug, by system L α-amino acid transporters: A comparative study in astrocytes, synaptosomes, and CHO cells. J Neurochem 1995; 64:2125-31
28. LoPachin RM, Rudy TA, Yaksh TL: An improved method for chronic catheterization of the rat spinal subarachnoid space. Physiol Behav 1981; 27:559-61
29. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL: Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994; 53:55-63
30. Zahn PK, Gysbers D, Brennan TJ: Effect of systemic and intrathecal morphine in a rat model of postoperative pain. ANESTHESIOLOGY 1997; 86:1066-77
31. Field MJ, Oles RJ, Lewis AS, McCleary S, Hughes J, Singh L: Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents. Br J Pharmacol 1997; 121:1513-22
32. 2+ block in NMDA receptor channels. J Neurosci 1996; 16:3549-58
33. 2+ ions in chick sensory neurones. J Physiol 1997; 504:1-15
34. Hamm J, Alessi DR, Biondi RM: Bi-functional, substrate mimicking RNA inhibits MSK1-mediated cAMP-response element-binding protein phosphorylation and reveals magnesium ion-dependent conformational changes of the kinase. J Biol Chem 2002; 277:45793-802
35. 2+ release channels (ryanodine receptors) by multiple mechanisms. J Biol Chem 1999; 274:32680-91
36. Amann R, Maggi CA: Ruthenium red as a capsaicin antagonist. Life Sci 1991; 49:849-56
37. Capponi AM, Rossier MF, Davies E, Vallotton MB: Calcium stimulates steroidogenesis in permeabilized bovine adrenal cortical cells. J Biol Chem 1988; 263:16113-7
38. Cibulsky SM, Sather WA: Block by ruthenium red of cloned neuronal voltage-gated calcium channels. J Pharmacol Exp Ther 1999; 289:1447-53
39. Ohkubo T, Shibata M, Takahashi H: The analgesia induced by intrathecal injection of ruthenium red. Pain 1993; 54:219-21
40. Zahn PK, Brennan TJ: Lack of effect of intrathecally administered Nmethyl-D-aspartate receptor antagonists in a rat model for postoperative pain. ANESTHESIOLOGY 1998; 88:143-56
41. Rock DM, Macdonald RL: The polyamine spermine has multiple actions on N-methyl-D-aspartate receptor single-channel currents in cultured cortical neurons. Mol Pharmacol 1992; 41:83-8
42. Prado WA, Machado Filho EB: Antinociceptive potency of aminoglycoside antibiotics and magnesium chloride: A comparative study on models of phasic and incisional pain in rats. Braz J Med Biol Res 2002; 35:395-403
43. Gu Y, Huang LY: Gabapentin actions on N-methyl-D-aspartate receptor channels are protein kinase C-dependent. Pain 2001; 93:85-92
44. Moore KA, Baba H, Woolf CJ: Gabapentin: Actions on adult superficial dorsal horn neurons. Neuropharmacology 2002; 43:1077-81
45. Partridge BJ, Chaplan SR, Sakamoto E, Yaksh TL: Characterization of the effects of gabapentin and 3-isobutyl-γ-aminobutyric acid on substance P-induced thermal hyperalgesia. ANESTHESIOLOGY 1998; 88:196-205
46. B agonists and gabapentin on mechanical hyperalgesia in models of neuropathic and inflammatory pain in the rat, Pain 2001; 90:217-26
47. Dixit RK, Bhargava VK: Neurotransmitter mechanisms in gabapentin antinociception. Pharmacology 2002; 65:198-203
48. Withyachumnarnkul B, Knigge KM: Melatonin concentration in cerebrospinal fluid, peripheral plasma and plasma of the confluens sinuum of the rat. Neuroendocrinology 1980; 30:382-8
49. 2δ subunits-structure and gabapentin binding. Mol Pharmacol 2001; 59:1243-8
50. Sutton KG, Martin DJ, Pinnock RD, Lee K, Scott RH: Gabapentin inhibits high-threshold calcium channel currents in cultured rat dorsal root ganglion neurones. Br J Pharmacol 2002; 135:257-65
51. 2δ auxiliary subunit: Structure, function and regulation. Receptors Channels 1999; 6:351-62
52. 2δ calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats. J Neurosci 2001; 21:1868-75
53. 2+ channels in synaptic transmission. Br J Pharmacol 2002; 135:1336-42
54. Abenzodiazepine receptor ligands in membranes from the rat forebrain. Neuropharmacology 1992; 31:895-8
55. 1 adenosine receptor function in rat brain by the polyamine, spermine. Neurosci Lett 1991; 124:183-6
56. 3H]3-PPP binding to sigma receptors. Eur J Pharmacol 1990; 184:203-4
57. 3H]nitrendipine binding to the voltage-sensitive calcium channel in rat brain. Eur J Pharmacol 1992; 225:167-9
58. Pullan LM, Keith RA, LaMonte D, Stumpo RJ, Salama AI: The polyamine spermine affects ω-conotoxin binding and function at N-type voltage-sensitive calcium channels. J Auton Pharmacol 1990; 10:213-9
59. + currents. Eur J Neurosci 1994; 6:412-9